BAF components of SWI/SNF complex have been confirmed to maintain an oligodendrocyte precursor cell (OPC)-like state in glioma stem cells, thereby providing novel candidates for targeted therapy in H3K27M-mutant gliomas [210]. This evidence concerns the gene BANF1 and central nervous system cancer.